Finance

Lists
0009K0:KOSDAQ
Aimed Bio Inc
â‚©23,050.00
-2.33%
(-550.00) 1D
Sep 10, 1:23:31 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 0009K0...
Open
â‚©23,500
High
â‚©23,700
Low
â‚©22,600
Mkt. cap
1.49T
Avg. vol.
133.78K
Volume
48.76K
P/E ratio
28.53
52-wk high
â‚©80,200
52-wk low
â‚©17,400
EPS
â‚©808
Shares outstanding
64.67M
Open
â‚©23,500
High
â‚©23,700
Low
â‚©22,600
Mkt. cap
1.49T
Avg. vol.
133.78K
Volume
48.76K
P/E ratio
28.53
52-wk high
â‚©80,200
52-wk low
â‚©17,400
EPS
â‚©808
Shares outstanding
64.67M
About Aimed Bio Inc
CEO-
Employees-
Founded2018
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
114.24M
37.98B
8.50B
20.20B
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-904.24M
1.19B
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.98B
13.00B
10.37B
11.68B
Operating expense
5.98B
12.46B
12.46B
11.68B
Total operating expenses
5.98B
12.46B
12.46B
11.68B
Operating income
-5.87B
25.52B
-3.96B
8.52B
Other non operating income
665.52M
5.60M
-1.40B
1.33B
EBT including unusual items
-5.20B
25.74B
-2.01B
9.85B
EBT excluding unusual items
-5.20B
25.76B
-779.96M
9.85B
Income tax expense
-
-9.18B
-
-1.03B
Effective tax rate
-
-35.67%
-
-10.44%
Other operating expenses
-
-
-
-
Net income
-5.20B
34.92B
-2.01B
10.88B
Net profit margin
-4,549.74%
91.95%
-23.66%
53.89%
Earnings per share
-
-
-
-
Interest and investment income
-
673.31M
2.54B
-
Interest expense
-
-23.82M
-105.22M
-
Net interest expenses
-
649.49M
2.44B
-
Depreciation and amortization charges
-
284.77M
745.13M
-
EBITDA
-5.52B
25.88B
-3.53B
8.99B
Gain or loss from assets sale
-
16.22M
-
4.08M
AI content may include mistakes. Learn more
Google apps